All articles tagged: Malignant neoplasm of prostate (C61)

Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a study published in the July issue of The Journal of Urology.Sakina Mohammed Mota, Ph.D., from Avenda Health, and colleagues compared physicians' performance using AI versus stan

Black patients are more likely to experience adverse cardiovascular outcomes after systemic androgen deprivation therapy (ADT) for prostate cancer, according to a study published online June 18 in JACC: CardioOncology.Biniyam G. Demissei, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and

A study finds that routine PSA screening for prostate cancer has a small impact on reducing deaths but leads to overdiagnosis and overtreatment. Researchers suggest reconsidering the current approach to prostate cancer screening. They propose individualized screening strategies based on age and risk factors to minimize harms and maximize benefits.

Improving fitness lowers the risk of prostate cancer, according to a study. Higher cardiorespiratory fitness reduces the likelihood of developing prostate cancer, emphasizing the importance of regular exercise for prevention.

For patients with clear-cell renal cell carcinoma (ccRCC), overall survival (OS) is improved for those receiving pembrolizumab versus placebo at a median follow-up of about 57 months, according to a study presented at the American Society of Clinical Oncology annual Genitourinary Cancers Symposium, held from Jan. 25 to 27 in San Francisco.Ton

For patients with localized prostate cancer, the rates of adverse outcomes associated with specific treatments vary for favorable- and unfavorable-prognosis disease, according to a study published online in the Jan. 23/30 issue of the Journal of the American Medical Association.Bashir Al Hussein Al Awamlh, M.D., from Vanderbilt Universi

Digital rectal examination (DRE) exhibits low diagnostic value as an independent test and supplementary measure to prostate-specific antigen (PSA) for detection of prostate cancer, according to a study published online Jan. 4 in European Urology Oncology.Akihiro Matsukawa, from the Medical University of Vienna in Austria, and colleagues

From 2000 to 2020, U.S. age-adjusted cancer mortality rates decreased significantly, but racial and ethnic disparities persisted for certain cancers, according to a research letter published online Jan. 12 in JAMA Health Forum.Anjali Gupta and Tomi Akinyemiju, Ph.D., from the Duke University School of Medicine in Durham, North Carolin

For patients with immunotherapy recalcitrant KRAS-mutated tumors, the cancer vaccine ELI-002 2P is safe and induces T-cell responses, according to a study published online Jan. 9 in Nature Medicine.Noting that the cancer vaccine ELI-002 2P enhances lymph node delivery and immune response using Amphiphile (Amph)-modification of G12D and

Outdoor air pollution is tied to a higher risk for nonlung cancers in older adults, according to a study published online Aug. 1 in Environmental Epidemiology.Yaguang Wei, Ph.D., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues examined associations of 10-year exposures to fine particulate matter (PM2.

Increasing body mass index (BMI) at age 18 years is associated with development of subsequent site-specific cancers in men, according to a study published online Nov. 6 in Obesity.Aron Onerup, M.D., Ph.D., from the University of Gothenburg in Sweden, and colleagues examined BMI at age 18 years and incident site-specific cancer (

Longer prostatic urethral length measured on prostate magnetic resonance imaging (MRI) is independently associated with a higher risk for developing late genitourinary (GU) toxicity after radiation therapy (RT) for prostate cancer, according to a study published online Oct. 17 in Academic Radiology.Joseph Lee, M.D., Ph.D., from the

In recent years, significant advancements have been made in the field of cancer research, specifically in understanding the DNA repair pathways associated with breast, ovarian, and prostate cancers. These breakthroughs hold the promise of revolutionizing cancer treatment strategies and providing hope to millions of patients worldwide.

At any given prostate-specific antigen (PSA) level, Black men are more likely than White men to develop prostate cancer, according to a study published online Nov. 6 in Cancer.Kyung Min Lee, Ph.D., from the VA Salt Lake City Health Care System, and colleagues predicted the likelihood of prostate cancer diagnosis on first biopsy for 75,29

New research highlights a breakthrough in advanced bladder cancer treatment, where a drug duo significantly extends patient survival, potentially reshaping global standard care practices.